Inflammation markers in older adults with respiratory viral infections
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the body's inflammatory response (immune system markers) differs between older adults who have a current respiratory virus infection and those who don't. Researchers will measure these markers to better understand how the body fights these common infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 60 or older
- If in the infected group: you have respiratory symptoms (fever, cough, congestion, or difficulty breathing) that started within the last 24–72 hours
- If in the infected group: you tested positive for influenza, RSV, or COVID-19 on a rapid test
- If in the control group: you tested negative for influenza, RSV, and COVID-19
- You do not have a weakened immune system from transplant, untreated HIV, or other severe immunosuppression
- You do not have an autoimmune disease (such as lupus, rheumatoid arthritis, or multiple sclerosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.
This study looks at how the immune system reacts to the flu in people of different ages. If you have flu symptoms and don't have cancer or take immune-suppressing drugs, you may be able to join.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
This study looks at how acute respiratory infections (like the flu, COVID-19, or RSV) affect older adults' daily functioning. If you are 60+ and in the hospital with one of these viruses, your participation would help doctors understand the lasting impact on independence and health.
This study looks at viral respiratory infections in people over 60 who are hospitalized. Researchers will collect and test a breathing sample (a simple nasal or throat swab) to understand which viruses cause infections in older adults and how to better treat them.
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
Hear when a new SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.